MOS
EVGN icon

MGO One Seven’s Evogene EVGN Stock Holding History

MGO One Seven’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,484
Closed -$12 – 752
2022
Q3 		$12 Sell
1,484
-50
-3% -$482 ﹤0.01% 710
2022
Q2 		$12K Sell
1,534
-1,000
-39% -$9.78K ﹤0.01% 640
2022
Q1 		$33K Hold
2,534
– – ﹤0.01% 667
2021
Q4 		$42K Sell
2,534
-140
-5% -$3.18K ﹤0.01% 659
2021
Q3 		$70K Sell
2,674
-14
-0.5% -$409 0.01% 597
2021
Q2 		$92K Sell
2,688
-572
-18% -$22.4K 0.01% 579
2021
Q1 		$164K Buy
3,260
+200
+7% +$12.4K 0.03% 522
2020
Q4 		$144K Buy
+3,060
New +$108K 0.03% 473

Other funds holding EVGN

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
JIC
Joel Isaacson & Co New York $3.02B AUM 21.81% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return

MGO One Seven's EVGN Position: Q4 2022 in Review

MGO One Seven sold out of Evogene (EVGN) in Q4 2022, closing a stake of 1,484 shares — an estimated $12 sold.

MGO One Seven first reported a position in EVGN in Q4 2020 and held it in 8 quarters. The position peaked at $164K in Q1 2021. 31 funds tracked by Wall St. Rank hold EVGN as of Q4 2022.

  • MGO One Seven reported no remaining Evogene position as of Q4 2022 after selling out during the quarter.
  • MGO One Seven sold 1,484 Evogene shares in Q4 2022, an estimated $12.
  • MGO One Seven first reported a position in Evogene in Q4 2020 and held it in 8 quarters.
  • MGO One Seven's Evogene position peaked at $164K in Q1 2021.
  • 31 funds tracked by Wall St. Rank held Evogene as of Q4 2022.

Based on MGO One Seven's 13F filing for Q4 2022, filed 25 Jan 2023.